121 related articles for article (PubMed ID: 18589157)
1. Interleukin-22 deficiency accelerates the rejection of full major histocompatibility complex-disparate heart allografts.
Kapessidou P; Poulin L; Dumoutier L; Goldman M; Renauld JC; Braun MY
Transplant Proc; 2008 Jun; 40(5):1593-7. PubMed ID: 18589157
[TBL] [Abstract][Full Text] [Related]
2. Chronic rejection of murine cardiac allografts discordant at the H13 minor histocompatibility antigen correlates with the generation of the H13-specific CD8+ cytotoxic T cells.
Yang J; Jaramillo A; Liu W; Olack B; Yoshimura Y; Joyce S; Kaleem Z; Mohanakumar T
Transplantation; 2003 Jul; 76(1):84-91. PubMed ID: 12865791
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts.
Poulin LF; Richard M; Le Moine A; Kiss R; McKenzie AN; Goldman M; Renauld JC; Van Snick J; Braun MY
Transplantation; 2003 Aug; 76(3):572-7. PubMed ID: 12923446
[TBL] [Abstract][Full Text] [Related]
4. Role of PECAM-1 in acute rejection of fully major histocompatibility complex class II-mismatched cardiac allografts in mice.
Schramm R; Menger MD; Schmits R; Harder Y; Kirsch S; Meier C; Schäfers HJ
Transplantation; 2007 Aug; 84(4):555-8. PubMed ID: 17713444
[TBL] [Abstract][Full Text] [Related]
5. Predominant expression of Th2 cytokines and interferon-gamma in xenogeneic cardiac grafts undergoing acute vascular rejection.
Singh NP; Guo L; Mhoyan A; Shirwan H
Transplantation; 2003 Mar; 75(5):586-90. PubMed ID: 12640294
[TBL] [Abstract][Full Text] [Related]
6. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation.
Liang Y; Christopher K; Finn PW; Colson YL; Perkins DL
Transplantation; 2007 Sep; 84(6):771-7. PubMed ID: 17893611
[TBL] [Abstract][Full Text] [Related]
7. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
[TBL] [Abstract][Full Text] [Related]
8. [Transfection with virus interleukin-10 to prolong murine heart allograft].
Yang DH; Wu MC; Peng MH; Tzakis A
Zhonghua Wai Ke Za Zhi; 2005 Jan; 43(2):87-91. PubMed ID: 15771810
[TBL] [Abstract][Full Text] [Related]
9. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model.
Li J; Simeoni E; Fleury S; Dudler J; Fiorini E; Kappenberger L; von Segesser LK; Vassalli G
Eur J Cardiothorac Surg; 2006 May; 29(5):779-83. PubMed ID: 16520057
[TBL] [Abstract][Full Text] [Related]
10. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH.
Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H
Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251
[TBL] [Abstract][Full Text] [Related]
11. A pathogenic role of IL- 17 at the early stage of corneal allograft rejection.
Chen H; Wang W; Xie H; Xu X; Wu J; Jiang Z; Zhang M; Zhou L; Zheng S
Transpl Immunol; 2009 Jul; 21(3):155-61. PubMed ID: 19358887
[TBL] [Abstract][Full Text] [Related]
12. Deletion of DOCK2, a regulator of the actin cytoskeleton in lymphocytes, suppresses cardiac allograft rejection.
Jiang H; Pan F; Erickson LM; Jang MS; Sanui T; Kunisaki Y; Sasazuki T; Kobayashi M; Fukui Y
J Exp Med; 2005 Oct; 202(8):1121-30. PubMed ID: 16230477
[TBL] [Abstract][Full Text] [Related]
13. Effects of noninherited maternal antigens on allotransplant rejection in a transgenic mouse model.
Akiyama Y; Caucheteux SM; Iwamoto Y; Guimezanes A; Kanellopoulos-Langevin C; Benichou G
Transplant Proc; 2005 May; 37(4):1940-1. PubMed ID: 15919511
[TBL] [Abstract][Full Text] [Related]
14. Donor CD4 T cells contribute to cardiac allograft vasculopathy by providing help for autoantibody production.
Win TS; Rehakova S; Negus MC; Saeb-Parsy K; Goddard M; Conlon TM; Bolton EM; Bradley JA; Pettigrew GJ
Circ Heart Fail; 2009 Jul; 2(4):361-9. PubMed ID: 19808360
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection.
Khattar M; Baum CE; Schroder P; Breidenbach JD; Haller ST; Chen W; Stepkowski S
PLoS One; 2019; 14(11):e0225624. PubMed ID: 31756235
[TBL] [Abstract][Full Text] [Related]
16. In vivo visualization of cardiac allograft rejection and trafficking passenger leukocytes using bioluminescence imaging.
Tanaka M; Swijnenburg RJ; Gunawan F; Cao YA; Yang Y; Caffarelli AD; de Bruin JL; Contag CH; Robbins RC
Circulation; 2005 Aug; 112(9 Suppl):I105-10. PubMed ID: 16159800
[TBL] [Abstract][Full Text] [Related]
17. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
18. Trichosanthin, an extract of Trichosanthes kirilowii, effectively prevents acute rejection of major histocompatibility complex-mismatched mouse skin allograft.
Gong Q; Deng D; Ding J; Wang C; Bian Z; Ye Z; Xu J
Transplant Proc; 2008 Dec; 40(10):3714-8. PubMed ID: 19100472
[TBL] [Abstract][Full Text] [Related]
19. The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts.
Kemter AM; Scheu S; Hüser N; Ruland C; Schumak B; Findeiß M; Cheng Z; Assfalg V; Arolt V; Zimmer A; Alferink J
Life Sci; 2015 Oct; 138():29-34. PubMed ID: 25744392
[TBL] [Abstract][Full Text] [Related]
20. IL-5 and eosinophils mediate the rejection of fully histoincompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma.
Braun MY; Desalle F; Le Moine A; Pretolani M; Matthys P; Kiss R; Goldman M
Eur J Immunol; 2000 May; 30(5):1290-6. PubMed ID: 10820374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
